Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adoptive Immunotherapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00026897
What this trial is testing

Trafficking of Indium-III-Labeled Cultured Immune Cells in Patients Undergoing Immunotherapy for Advanced Cancer

Who this might be right for
Neoplasm
National Cancer Institute (NCI) 100
Testing effectiveness (Phase 2)Study completedNCT00394381
What this trial is testing

Autologous Cytokine-induced Killer Cell Adoptive Immunotherapy for Acute Myeloid Leukemia and Myelodysplastic Syndrome

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndrome, High Grade
Singapore General Hospital 17
Not applicableStudy completedNCT00001353
What this trial is testing

Safety and Survival of Genetically Modified White Blood Cells in HIV-Infected Persons - A Study in Identical Twin Pairs

Who this might be right for
Acquired Immunodeficiency SyndromeHIV Infection
National Institute of Allergy and Infectious Diseases (NIAID) 24
Testing effectiveness (Phase 2)Ended earlyNCT03709706
What this trial is testing

Pilot Immunotherapy Study With Letetresgene Autoleucel (Lete-cel, GSK3377794)T-cells in New York Esophageal Squamous Cell Carcinoma-1 (NY-ESO-1)/ LAGE-1a-positive Advanced Non-small Cell Lung Cancer (NSCLC) Either Alone or in Combination With Pembrolizumab

Who this might be right for
Neoplasms
GlaxoSmithKline 34
Early research (Phase 1)Study completedNCT00512889
What this trial is testing

Adoptive Transfer of MART1/Melan-A CTL for Malignant Melanoma

Who this might be right for
Melanoma (Skin)
Dana-Farber Cancer Institute 9
Early research (Phase 1)Ended earlyNCT01585415
What this trial is testing

Vemurafenib and White Blood Cell Therapy for Advanced Melanoma

Who this might be right for
Metastatic CancerMelanoma
National Cancer Institute (NCI) 12
Testing effectiveness (Phase 2)Ended earlyNCT01468818
What this trial is testing

Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Melanoma

Who this might be right for
Metastatic MelanomaSkin Cancer
National Cancer Institute (NCI) 18
Early research (Phase 1)Active Not RecruitingNCT01955460
What this trial is testing

Genetically Modified T-Cells Followed by Aldesleukin in Treating Patients With Stage III-IV Melanoma

Who this might be right for
Metastatic MelanomaStage III Cutaneous Melanoma AJCC v7Stage IIIA Cutaneous Melanoma AJCC v7+3 more
M.D. Anderson Cancer Center 34
Testing effectiveness (Phase 2)Looking for participantsNCT07467863
What this trial is testing

Dual-Target CAR-NK Cells Directed Against MSLN, EGFR, or HER2 in Advanced NSCLC

Who this might be right for
Non-Small Cell Lung CancerAdvanced/Metastatic NSCLC
Beijing Biotech 48
Early research (Phase 1)Study completedNCT00834665
What this trial is testing

Phase I/II Clinical Trial Combining hTERT Tumor Vaccine & Autologous T Cells in Patients With Advanced Myeloma

Who this might be right for
Multiple Myeloma
University of Pennsylvania 59
Testing effectiveness (Phase 2)Ended earlyNCT00531310
What this trial is testing

Reduced Intensity AlloSCT in(CML) With Persistent Disease

Who this might be right for
Chronic Myeloid Leukemia
Columbia University 5
Early research (Phase 1)Study completedNCT00182650
What this trial is testing

Cellular Adoptive Immunotherapy in Treating Patients With Relapsed or Refractory Follicular Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
City of Hope Medical Center 5
Early research (Phase 1)WithdrawnNCT05393635
What this trial is testing

ITIL-168 in Advanced Solid Tumors

Who this might be right for
Cervical CancerHead and Neck Squamous Cell CarcinomaNon-small Cell Lung Cancer
Instil Bio
Testing effectiveness (Phase 2)Looking for participantsNCT07598955
What this trial is testing

Target-Selected CAR-NK Cells (CD30, CD5, or Mesothelin) for Relapsed/Refractory B2 Thymoma or Thymic Carcinoma

Who this might be right for
B2 ThymomaThymic Carcinoma
Beijing Biotech 36
Early research (Phase 1)Active Not RecruitingNCT02862275
What this trial is testing

Atezolizumab in Treating Patients With Cancer Following Adoptive Cell Transfer

Who this might be right for
Hematopoietic and Lymphoid Cell NeoplasmMetastatic Malignant Solid NeoplasmUnresectable Malignant Solid Neoplasm
National Cancer Institute (NCI) 40
Testing effectiveness (Phase 2)Looking for participantsNCT07641023
What this trial is testing

Dual-Target CAR-NK Cells Targeting MSLN, EGFR, or HER2 in Advanced NSCLC

Who this might be right for
Non-Small Cell Lung CancerAdvanced/Metastatic
Beijing Biotech 60
Not applicableNo Longer AvailableNCT00547235
What this trial is testing

Emergency Use of Adoptive Immunotherapy With CMV-Specific T Cells After Donor Bone Marrow Transplant of an Infant With Immunodeficiency Syndrome and CMV Infection

Who this might be right for
InfectionPrecancerous/Nonmalignant Condition
Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)WithdrawnNCT03419559
What this trial is testing

Study of Autologous Tumor Infiltrating Lymphocytes (LN-145) In Combo With Durvalumab in Non-Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Iovance Biotherapeutics, Inc.
Testing effectiveness (Phase 2)UnknownNCT03410368
What this trial is testing

NK Cell-based Immunotherapy as Maintenance Therapy for Small-Cell Lung Cancer.

Who this might be right for
Small Cell Lung Cancer
jiuwei cui 120
Testing effectiveness (Phase 2)Study completedNCT00499577
What this trial is testing

Stem Cell Transplant, Chemotherapy, and Biological Therapy in Treating Patients With High-Risk or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
University of Maryland Greenebaum Cancer Center 56
Next Page